Dow Up 0.76% Nasdaq Up 0.69%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
8.75 Down 0.47(5.10%) Oct 24, 4:00PM EDT
|After Hours : 8.75 0.00 (0.00%) Oct 24, 7:14PM EDT
Prev Close:9.22
Open:8.95
Bid:N/A
Ask:11.72 x 3000
1y Target Est:15.27
Beta:2.08
Next Earnings Date:N/A
Day's Range:8.70 - 9.66
52wk Range:7.70 - 18.19
Volume:1,743,370
Avg Vol (3m):1,035,550
Market Cap:751.69M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMGN

Comparison

Symbol% ChgMkt Cap
IMGNDown 5.10%751.69M
PFEUp 1.78%184.58B
RHHBYDown 0.19%248.56B
SGENUp 0.98%4.44B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.73
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback